Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 8:30 AM View:  | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 25-Apr-24 | Purchase | 8,600 | $3.24 | $27,864.00 | 5% 180.12K to 188.72K | |
| Yesterday 8:30 AM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 25-Apr-24 | Purchase | 5,608 | $3.14 | $17,609.10 | 2% 228.26K to 233.87K | |
| 15-Mar-24 5:00 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 15-Mar-24 | Payment of Exercise | 703 | $8.14 | $5,722.42 | (< 1%) 228.96K to 228.26K | |
| 12-Mar-24 5:00 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 04-Mar-24 | Payment of Exercise | 183 | $7.81 | $1,429.23 | (< 1%) 180.3K to 180.12K | |
| 07-Feb-24 8:30 AM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 06-Feb-24 | Purchase | 20,000 | $4.39 | $87,800.00 | 4% 508.26K to 528.26K | |
| 22-Jan-24 4:30 PM View: | Alvino Mark Director | Access Pharmaceuticals Inc. (ABEO) | 17-Jan-24 | Private Sale | 7,084 | $5.11 | $36,199.20 | (10%) 69.9K to 62.82K | |
| 17-Oct-23 4:30 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 16-Oct-23 | Payment of Exercise | 181 | $4.14 | $749.34 | (< 1%) 508.44K to 508.26K | |
| 29-Sep-23 5:16 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 29-Sep-23 | Payment of Exercise | 6,557 | $3.93 | $25,769.00 | (4%) 186.86K to 180.3K | |
| 29-Sep-23 5:17 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 29-Sep-23 | Payment of Exercise | 6,230 | $3.93 | $24,483.90 | (3%) 235.19K to 228.96K | |
| 29-Sep-23 5:25 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 29-Sep-23 | Payment of Exercise | 13,290 | $3.93 | $52,229.70 | (3%) 521.73K to 508.44K | |
| 29-Sep-23 4:30 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Private Sale | 5,508 | $3.91 | $21,542.30 | (5%) 114.47K to 108.96K | |
| 29-Sep-23 4:30 PM View: | Alvino Mark Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Private Sale | 6,316 | $3.91 | $24,724.00 | (8%) 76.22K to 69.9K | |
| 29-Sep-23 4:30 PM View: | Silverstein Christine Berni Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Private Sale | 6,330 | $3.91 | $24,721.20 | (7%) 94.21K to 87.88K | |
| 29-Sep-23 4:30 PM View: | Alland Leila Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Private Sale | 7,246 | $3.90 | $28,269.50 | (9%) 79.1K to 71.86K | |
| 29-Sep-23 7:30 AM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Purchase | 20,000 | $4.07 | $81,400.00 | 4% 501.73K to 521.73K | |
| 29-Sep-23 4:30 PM View: | Charles Faith L. Director | Access Pharmaceuticals Inc. (ABEO) | 27-Sep-23 | Private Sale | 8,330 | $4.91 | $40,923.60 | (11%) 79.1K to 70.77K | |
| 22-Sep-23 4:05 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 21-Sep-23 | Payment of Exercise | 563 | $3.80 | $2,139.40 | (< 1%) 187.42K to 186.86K | |
| 22-Sep-23 4:05 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 20-Sep-23 | Private Sale | 327 | $3.90 | $1,275.30 | (< 1%) 114.79K to 114.47K | |
| 20-Sep-23 9:00 AM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 19-Sep-23 | Purchase | 3,000 | $3.82 | $11,458.30 | 1% 235.18K to 238.18K | |
| 19-Sep-23 9:00 AM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 18-Sep-23 | Purchase | 3,000 | $3.80 | $11,400.00 | 2% 184.42K to 187.42K | |
| 25-Jul-23 8:10 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 24-Jul-23 | Payment of Exercise | 1,187 | $3.73 | $4,427.51 | (< 1%) 236.37K to 235.18K | |
| 21-Jun-23 4:05 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 20-Jun-23 | Private Sale | 338 | $4.45 | $1,504.10 | (< 1%) 115.13K to 114.79K | |
| 16-Jun-23 4:05 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 14-Jun-23 | Grant | 58,689 | $4.62 | $271,143.00 | 104% 56.44K to 115.13K | |
| 16-Jun-23 4:05 PM View: | Wuchterl Donald A. Director | Access Pharmaceuticals Inc. (ABEO) | 14-Jun-23 | Grant | 58,689 | $4.62 | $271,143.00 | 287% 20.41K to 79.1K | |
| 16-Jun-23 4:05 PM View: | Alvino Mark Director | Access Pharmaceuticals Inc. (ABEO) | 14-Jun-23 | Grant | 58,689 | $4.62 | $271,143.00 | 335% 17.53K to 76.22K | |
| 16-Jun-23 4:05 PM View: | Charles Faith L. Director | Access Pharmaceuticals Inc. (ABEO) | 14-Jun-23 | Grant | 58,689 | $4.62 | $271,143.00 | 287% 20.41K to 79.1K | |
| 16-Jun-23 4:05 PM View: | Silverstein Christine Berni Director | Access Pharmaceuticals Inc. (ABEO) | 14-Jun-23 | Grant | 58,689 | $4.62 | $271,143.00 | 165% 35.52K to 94.21K | |
| 16-Jun-23 4:05 PM View: | Alland Leila Director | Access Pharmaceuticals Inc. (ABEO) | 14-Jun-23 | Grant | 58,689 | $4.62 | $271,143.00 | 287% 20.41K to 79.1K | |
| 07-Jun-23 4:15 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 05-Jun-23 | Grant | 141,908 | -- | -- | 150% 94.46K to 236.37K | |
| 07-Jun-23 4:15 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 05-Jun-23 | Grant | 336,826 | -- | -- | 204% 164.91K to 501.73K | |
| 07-Jun-23 4:15 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 05-Jun-23 | Grant | 90,902 | -- | -- | 97% 93.52K to 184.42K | |
| 06-Jun-23 4:15 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 02-Jun-23 | Payment of Exercise | 827 | $3.06 | $2,530.62 | (< 1%) 165.73K to 164.91K | |
| 05-May-23 4:05 PM View: | Alvino Mark Director | Access Pharmaceuticals Inc. (ABEO) | 25-Apr-23 | Private Sale | 887 | $3.25 | $2,882.75 | (5%) 18.41K to 17.53K | |
| 05-Apr-23 4:23 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 03-Apr-23 | Payment of Exercise | 104 | $2.82 | $293.28 | (< 1%) 93.62K to 93.52K | |
| 21-Mar-23 5:13 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 20-Mar-23 | Private Sale | 268 | $2.33 | $624.44 | (< 1%) 56.71K to 56.44K | |
| 17-Mar-23 4:05 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 15-Mar-23 | Payment of Exercise | 792 | $2.60 | $2,059.20 | (< 1%) 95.25K to 94.46K | |
| 03-Mar-23 10:00 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 03-Mar-23 | Payment of Exercise | 207 | $2.28 | $471.96 | (< 1%) 93.83K to 93.62K | |
| 03-Mar-23 10:00 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 03-Mar-23 | Private Sale | 1,002 | $2.38 | $2,384.76 | (2%) 57.71K to 56.71K | |
| 12-Dec-22 4:10 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 09-Dec-22 | Purchase | 5,869 | $3.13 | $18,370.00 | 7% 87.96K to 93.83K | |
| 21-Nov-22 9:00 AM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 18-Nov-22 | Purchase | 7,500 | $3.99 | $29,925.00 | 9% 80.46K to 87.96K | |
| 21-Nov-22 9:00 AM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 18-Nov-22 | Purchase | 2,500 | $4.00 | $10,000.00 | 3% 92.75K to 95.25K | |
| 18-Oct-22 4:05 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 17-Oct-22 | Payment of Exercise | 207 | $4.30 | $890.10 | (< 1%) 165.94K to 165.73K | |
| 30-Sep-22 4:05 PM View: | Vazzano Joseph Walter Chief Financial Officer | Access Pharmaceuticals Inc. (ABEO) | 28-Sep-22 | Grant | 72,750 | -- | -- | 364% 20.0K to 92.75K | |
| 30-Sep-22 4:05 PM View: | Seshadri Vishwas Chief Executive Officer Director | Access Pharmaceuticals Inc. (ABEO) | 28-Sep-22 | Grant | 155,200 | -- | -- | 1445% 10.74K to 165.94K | |
| 30-Sep-22 4:05 PM View: | O'Malley Brendan M. SVP, General Counsel | Access Pharmaceuticals Inc. (ABEO) | 28-Sep-22 | Grant | 72,750 | -- | -- | 943% 7.71K to 80.46K | |
| 28-Sep-22 4:36 PM View: | Amoroso Michael Director | Access Pharmaceuticals Inc. (ABEO) | 26-Sep-22 | Grant | 13,400 | -- | -- | 30% 44.31K to 57.71K | |
| 28-Sep-22 4:41 PM View: | Charles Faith L. Director | Access Pharmaceuticals Inc. (ABEO) | 26-Sep-22 | Grant | 13,400 | -- | -- | 191% 7.01K to 20.41K | |
| 28-Sep-22 4:36 PM View: | Wider Todd Director | Access Pharmaceuticals Inc. (ABEO) | 26-Sep-22 | Grant | 13,400 | -- | -- | 382% 3.51K to 16.91K | |
| 28-Sep-22 4:34 PM View: | Mann Paul Elliot Director | Access Pharmaceuticals Inc. (ABEO) | 26-Sep-22 | Grant | 13,400 | -- | -- | 382% 3.51K to 16.91K | |
| 28-Sep-22 4:33 PM View: | Alvino Mark Director | Access Pharmaceuticals Inc. (ABEO) | 26-Sep-22 | Grant | 13,400 | -- | -- | 267% 5.01K to 18.41K |
